SIBN - SI-BONE, Inc.
NEXT EARNINGS:
May 11, 2026
EPS Est: $-0.19
|
Rev Est: $51.2M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$25.25
DETAILS
HIGH:
$27.00
LOW:
$23.00
MEDIAN:
$25.50
CONSENSUS:
$25.25
UPSIDE:
65.14%
Market Cap:
663.45M
Volume:
1,689,594
Avg Volume:
510,346
52 Week Range:
12.5-21.89
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.68
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
349
IPO Date:
2018-10-17
EPS (TTM):
-0.44
P/E Ratio:
-45.38
Revenue (TTM):
200.93M
Total Assets:
238.56M
Total Debt:
1.12M
Cash & Equiv:
42.24M
Rev Growth (5Y):
22.3%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
N/A
Debt/Equity:
0.01
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-23 | $-0.04 | $-0.13 | +69.2% | $56.4M | $52.7M | +7.0% |
| 2025-11-10 | $-0.11 | $-0.16 | +31.2% | $48.7M | $56.3M | -13.5% |
| 2025-08-04 | $-0.14 | $-0.19 | +26.3% | $48.6M | $46.7M | +4.2% |
| 2025-05-05 | $-0.15 | $-0.24 | +37.5% | $47.3M | $46.7M | +1.2% |
| 2025-02-24 | $-0.11 | $-0.15 | +24.4% | $49.0M | $48.1M | +1.8% |
| 2024-11-12 | $-0.16 | $-0.22 | +27.3% | $40.3M | $46.9M | -14.0% |
| 2024-08-05 | $-0.22 | $-0.26 | +15.4% | $40.0M | $38.3M | +4.3% |
| 2024-05-06 | $-0.27 | $-0.29 | +6.9% | $37.9M | $36.5M | +3.8% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 200.93M | 167.18M | 138.89M | 106.41M | 90.15M | 73.39M | 67.30M | 55.38M | 47.98M | 42.10M | 41.17M | 40.05M |
| Net Income | (18.91M) | (30.91M) | (43.34M) | (61.26M) | (56.57M) | (43.70M) | (38.40M) | (17.45M) | (23.04M) | (20.59M) | (28.15M) | (27.81M) |
| EPS | -0.44 | -0.75 | -1.13 | -1.79 | -1.71 | -1.50 | -1.72 | -1.10 | -1.66 | -1.33 | -1.17 | -10.42 |
| Total Assets | 238.56M | 230.44M | 230.43M | 157.55M | 190.51M | 223.14M | 117.01M | 138.52M | 35.83M | 39.44M | 36.05M | 28.98M |
| Total Debt | 1.12M | 37.48M | 38.99M | 39.43M | 40.48M | 39.45M | 39.22M | 38.96M | 38.70M | 29.31M | 25.06M | 15.15M |
| Cash & Equivalents | 42.24M | 34.95M | 33.27M | 20.72M | 63.42M | 53.58M | 10.44M | 25.12M | 22.41M | 27.90M | 20.27M | 17.60M |
| Operating Cash Flow | (675,000) | (12.43M) | (18.71M) | (41.66M) | (39.53M) | (30.66M) | (31.63M) | (14.52M) | (17.53M) | (16.75M) | (26.72M) | (26.33M) |
| Free Cash Flow | (9.09M) | (22.92M) | (26.51M) | (51.16M) | (45.92M) | (33.22M) | (34.07M) | (15.46M) | (18.01M) | (17.19M) | (28.96M) | (29.20M) |
| FCF per Share | -0.21 | -0.55 | -0.69 | -1.50 | -1.39 | -1.14 | -1.38 | -0.97 | -1.30 | -1.11 | -1.20 | -10.94 |
| Book Value | 177.53M | 166.96M | 169.38M | 98.30M | 134.42M | 169.36M | 63.01M | 90.19M | (129.38M) | (108.73M) | 3.23M | 6.89M |
| Cash & ST Investments | 147.82M | 150.04M | 166.02M | 97.29M | 146.98M | 196.43M | 91.78M | 122.22M | 22.41M | 27.90M | 20.27M | 17.60M |
| ROC Equity | -0.11 | -0.19 | -0.26 | -0.62 | -0.42 | -0.26 | -0.61 | -0.19 | N/A | N/A | -8.71 | -4.03 |